CN Stock MarketDetailed Quotes
300267 Hunan Er-kang Pharmaceutical
- 3.23
- +0.02+0.62%
Market Closed Dec 20 15:00 CST
6.66BMarket Cap-25.63P/E (TTM)
3.27High3.17Low301.08KlotVolume3.20Open3.21Pre Close96.91MTurnover2.12%Turnover RatioLossP/E (Static)2.06BShares3.8852wk High1.41P/B4.59BFloat Cap2.0352wk Low3.85Limit Up1.42BShs Float23.06Historical High2.57Limit Down3.12%Amplitude1.20Historical Low--Dividend TTM3.22Avg Price153.58KlotAsk--Div YieldTTM100Lot Size143.69KlotBid
Hunan Er-kang Pharmaceutical Key Stats
EPS
According to the latest financial report of Hunan Er-kang Pharmaceutical, the latest earnings per share (TTM) for the company is -0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Hunan Er-kang Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 2.29.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hunan Er-kang Pharmaceutical shows that the company's current ratio is 2.68, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hunan Er-kang Pharmaceutical, the quick ratio is 1.64, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Hunan Er-kang Pharmaceutical? The latest ROE figure is -0.53%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hunan Er-kang Pharmaceutical, the total asset return on investment (ROA) is -0.49%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hunan Er-kang Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 30.94%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hunan Er-kang Pharmaceutical, the net profit margin is -3.15%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
